Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jun;16(2):189-96.
doi: 10.1007/s10006-012-0335-8. Epub 2012 May 17.

Correlation of expression of hypoxia-related proteins with prognosis in oral squamous cell carcinoma patients

Affiliations
Review

Correlation of expression of hypoxia-related proteins with prognosis in oral squamous cell carcinoma patients

A W Eckert et al. Oral Maxillofac Surg. 2012 Jun.

Abstract

Introduction: Hypoxia plays a major role in tumor progression, therapy resistance and for prognosis of oral squamous cell carcinoma (OSCC). The crucial step as a response to hypoxia is the activation and stabilization of the alpha subunit of hypoxia inducible factor 1 (HIF-1α). HIF-1: HIF-1 regulates the expression of different genes to adapt the tumor cells to reduced oxygenation. The HIF-1 system is intrinsic regulated by von Hippel-Lindau protein (pVHL). Main downstream proteins are the glucose transporter 1 (GLUT-1), carbonic anhydrase IX (CAIX), and vascular endothelial growth factor (VEGF). For therapeutical stratification in OSCC, it is important to understand the mechanism caused by hypoxic stress and to comprehend the resulting adaptive process in cancer cells. Therefore, an overview of HIF-1α-depending protein expression, focussed on the expression of GLUT-1, CAIX, and VEGF and their prognostic significance in OSCC is given.

Conclusion: Several unique roles of hypoxic pathway in the context of tumor progression are described in this review. As a consequence, a marker panel is proposed to allow a more individualized prognosis in OSCC patients. This marker panel should include beside HIF-1α, pVHL, and GLUT-1.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Clin Cancer Res. 2005 Feb 15;11(4):1434-40 - PubMed
    1. Head Neck. 2012 Jul;34(7):929-36 - PubMed
    1. J Oral Pathol Med. 2010 Apr;39(4):313-7 - PubMed
    1. Oral Oncol. 2009 Mar;45(3):241-6 - PubMed
    1. Adv Exp Med Biol. 2008;614:127-36 - PubMed

MeSH terms

Substances

LinkOut - more resources